Physician profile
Barbara E Ross
NPI 1104239870
$4,638.44
in general payments reported to CMS, 2019-2025
9 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,156 · 2020: $144 · 2021: $100 · 2022: $64.58 · 2023: $165 · 2024: $554 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,354.66 | 2019-2025 | Actishield, Ortholoc 2 Lapifuse, Prostep Mica |
| Sequoia Surgical, INC. | $1,266.61 | 2019 | |
| Smith+Nephew, INC. | $372.92 | 2019-2024 | Collagenase Santyl, Regranex |
| Bioventus LLC | $268.05 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $182.03 | 2023-2025 | Motoband |
| Wright Medical Technology, INC. | $84.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $45.00 | 2019 | |
| Evolution Surgical, INC | $34.60 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.22 | 2023-2025 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.